A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Inclusion Criteria: * Healthy male or female subjects between the ages of \>=11 and \<=18 years at the time of enrollment. * Negative urine pregnancy test for all female subjects. * Parent/legal guardian or subject under supervision of the parent/legal guardian must be able to complete all relevant study procedures during study participation. Exclusion Criteria: * History of any invasive meningococcal disease. * A previous anaphylactic or severe vaccine-associated adverse reaction. * Any clinically significant chronic disease. * A known or suspected disease of the immune system or those receiving immunosuppressive therapy, including systemic corticosteroids. Topical, inhaled or intra-articular corticosteroids are allowed. * Participation in another investigational study in the 1-month (30-day) period before study visit 1 and during the conduct of the study.